Programmable Probiotics for Cancer
Programmable Probiotics for Cancer
批准号:
9189187
负责人:
Tal Danino
金额:
$24.9万
依托单位国家:
美国
项目类别:
财政年份:
2016
资助国家:
美国
项目状态:
已结题
起止时间:
2016-04-01 至 2019-03-31
关键词:
AddressAdenocarcinomaApoptoticBacteriaBacterial LuciferasesBehaviorBindingBiological MarkersCancer ModelCell LineCellsCleaved cellColorectalColorectal CancerComputer SimulationCytolysisDataDetectionDevelopmentDiagnosisDiagnosticDimensionsDose-LimitingEngineeringEnvironmentEnzyme-Linked Immunosorbent AssayFluorescenceGenesGeneticGenetically Engineered MouseGrowthHealthHistocompatibility TestingHomingHourHumanHuman bodyImageImmune responseImmunocompetentIn VitroInfectionInjectableIntestinesLaboratoriesLuciferasesMDA MB 435Malignant NeoplasmsMeasurementMeasuresMembrane ProteinsMentorsMetastatic Neoplasm to the LiverMethodsMicrobeMicrofluidic MicrochipsMicrofluidicsMicroscopyModelingMonitorMusNecrosisOralOral AdministrationOxygenPaperPeptidesPharmaceutical PreparationsPhasePolypsPopulationPopulation DensityPrevalenceProbioticsProductionResearchRibosomesScienceSensitivity and SpecificitySpecificityStagingSurfaceTechnologyTestingTherapeuticTimeTissuesToxic effectTranslatingTranslationsUrineWeightbaseclinical applicationclinically relevantdesigndosageengineering designimaging systemimprovedin vivoin vivo imagingintravenous administrationmathematical modelmicrobialmicrobiomemouse modeloptimismpathogenpeptide drugpre-clinicalpromoterreceptorsubcutaneoussynthetic biologytargeted treatmenttime usetranslational medicinetumortumor progressionuptakevector
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Over the past decade, the long-held view of bacteria as pathogens has been transformed by microbiome data revealing an astounding prevalence of microbes within the human body. These bacteria exist not only in well- known regions such as the intestines, but also in a multitude of tissue types including tumors. Given this prevalence, microbes represent a natural platform for the development of diagnostics and therapies engineered to sense their environment and deliver drugs to tumors. Current & Mentored Research: Our preliminary results have shown that oral delivery of probiotic bacteria can colonize colorectal liver metastases and enzymatically cleave an injected substrate that can be detected in the urine (Danino et al., Science Translational Medicine, in revision). Building upon this result to improve sensitivity and specificity, we will engineer a gene circuit to lyse at a threshold population density within the tumor environment and release a urine diagnostic peptide. Circuit parameters will be predicted by mathematical modeling, characterized by microfluidic measurements, and experimentally tuned by genetic copy number and ribosome binding strengths to optimize for detection of the diagnostic peptide in mouse models. Independent Phase Research: Following initial characterization of the engineered diagnostic circuit, we will assess colonization in more realistic orthotopic and genetically engineered mouse models of colorectal cancer. We will determine earliest stages at which bacteria colonization occurs and simultaneously measure diagnostic peptide concentrations in the urine. We will target our probiotics with tumor-homing peptides, express pro- apoptotic peptides as therapeutics, and monitor progression of tumors as a function of time. Altogether, the programmable probiotic platform will allow for more sophisticated microbial diagnostics and therapeutics for cancer and establish an engineering framework for in vivo applications for synthetic biology.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Engineering probiotics for tuberculosis therapy
-
批准号:10511520
-
项目类别:
-
资助金额:$28.97万
-
财政年份:2022
-
负责人:Tal Danino
-
依托单位:
Engineering probiotics for tuberculosis therapy
-
批准号:10629371
-
项目类别:
-
资助金额:$23.39万
-
财政年份:2022
-
负责人:Tal Danino
-
依托单位:
Probiotic guided CAR-T therapy (ProCARs) for breast cancer
-
批准号:10681319
-
项目类别:
-
资助金额:$66.45万
-
财政年份:2020
-
负责人:Tal Danino
-
依托单位:
Probiotic guided CAR-T therapy (ProCARs) for breast cancer
-
批准号:10034374
-
项目类别:
-
资助金额:$66.04万
-
财政年份:2020
-
负责人:Tal Danino
-
依托单位:
Engineering S. typhimurium for metastatic colorectal cancer
-
批准号:9973552
-
项目类别:
-
资助金额:$34.67万
-
财政年份:2020
-
负责人:Tal Danino
-
依托单位:
Engineering immunotherapeutic probiotics to mitigate irAE
-
批准号:10378953
-
项目类别:
-
资助金额:$4.34万
-
财政年份:2020
-
负责人:Tal Danino
-
依托单位:
Probiotic guided CAR-T therapy (ProCARs) for breast cancer
-
批准号:10447144
-
项目类别:
-
资助金额:$67.69万
-
财政年份:2020
-
负责人:Tal Danino
-
依托单位:
Probiotic guided CAR-T therapy (ProCARs) for breast cancer
-
批准号:10263960
-
项目类别:
-
资助金额:$67.51万
-
财政年份:2020
-
负责人:Tal Danino
-
依托单位:
Engineering S. typhimurium for metastatic colorectal cancer
-
批准号:10532672
-
项目类别:
-
资助金额:$35.79万
-
财政年份:2020
-
负责人:Tal Danino
-
依托单位:
Programmable Probiotics for Cancer
-
批准号:9252421
-
项目类别:
-
资助金额:$22.07万
-
财政年份:2016
-
负责人:Tal Danino
-
依托单位:
Bacterial Minicells for Cancer Therapeutics
-
批准号:8820071
-
项目类别:
-
资助金额:$2.79万
-
财政年份:2014
-
负责人:Tal Danino
-
依托单位:
Bacterial Minicells for Cancer Therapeutics
-
批准号:8525773
-
项目类别:
-
资助金额:$5.22万
-
财政年份:2014
-
负责人:Tal Danino
-
依托单位:
Engineered gene circuits for basic science and biotechnology
-
批准号:9751306
-
项目类别:
-
资助金额:$57.84万
-
财政年份:2004
-
负责人:Tal Danino
-
依托单位:
Engineered gene circuits for basic science and biotechnology
-
批准号:9177553
-
项目类别:
-
资助金额:$60.45万
-
财政年份:2004
-
负责人:Tal Danino
-
依托单位:
Engineered gene circuits for basic science and biotechnology
-
批准号:9314573
-
项目类别:
-
资助金额:$58.62万
-
财政年份:2004
-
负责人:Tal Danino
-
依托单位:
国内基金
海外基金
大肠癌发生机制的adenoma-adenocarcinoma pathway同serrated pathway的关系的研究
-
批准号:30840003
-
项目类别:专项基金项目
-
资助金额:12.0万元
-
批准年份:2008
-
负责人:焦宇飞
-
依托单位: